Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Y1 - PoM - Week 1 > Haemostasis > Flashcards

Haemostasis Flashcards

1
Q

How is normal haemostasis of the blood maintained and using which factors?

A

A state of equilibrium is established between fibrinolytic factors (anti-coagulant proteins) and coagulation factors (platelets)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why is this balance important? (3 things this system does)

A
  1. Coagulation - stimulation of blood clotting processes following injury
  2. Thrombosis - Limit response to the site of injury (to prevent excessive blood clotting)
  3. Fibrinolysis - Start the process of the breakdown of the clot
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Haemostasis following trauma to blood vessels:

A
  1. Vasoconstriction
  2. Primary haemostasis - formation of an unstable platelet plug using platelet adhesion and platelet aggregation
  3. Secondary haemostasis/coagulation - formation of a stable fibrin clot
  4. Fibrinolysis - dissolution of clot and vessel repair
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is haemostasis?

A

Prevention of blood loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Where are platelets derived from and what is their lifespan?

A

From myeloid stem cells, which differentiate to megakaryocytes, which fragment to form platelets.
Have a lifespan of 8-10 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 4 steps of primary haemostasis?

A
  1. Platelet adhesion
  2. Platelet activation/ release action
  3. Thromboxane A2 synthesis
  4. Platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The method of platelet adhesion following injury?

A

Platelets stick to the damaged endothelium in two ways:

  1. The GPIa receptor on the platelets directly attaches to the damaged vessel
  2. The GPIb receptor on the platelets binds to von Willebrand factor (VWF) which is attached to the damaged vessel
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What happens during platelet activation / release reaction?

A

The adhesion of the platelets activates them - they release the contents of their storage granules including ADP, Ca2+, fibrinogen and VWF
The GPIa and GPIb receptors also change shape so they can bind to fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is thromboxane A2 synthesised?

A

From arachidonic acid, using the cyclooxygenase enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why is the release of thromboxane A2 important?

A

Release of ADP and generation of thromboxane A2 have positive feedback effects resulting in further platelet recruitment activation and aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How are platelets aggregated?

A

Using fibrinogen, which binds to platelets and links them together to form the platelet plug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is this process counteracted / returned to normal?

A

Prostacyclin released from the endothelial cells causes vasodilation, and suppresses platelet activation and consequently prevents (inappropriate) aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are 2 common anti-platelet drugs?

A

Aspirin and Clopidogrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does Aspirin work?

A

Aspirin inhibits the cyclooxygenase enzyme to block thromboxane A2 production, which reduces platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How long do the effects of aspirin last?

A

7 days - until the platelets at the time of aspirin ingestion have been replaced by new platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does Clopidogrel work?

A

Irreversibly blocks the ADP receptor (P2Y12) on the platelet cell membrane, again reducing platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How long do the effects of Clopidogrel last?

A

Same as Aspirin - 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is secondary haemostasis (coagulation) and why is it important?

A

It is the formation of a fibrin clot that stabilises the initial primary platelet plug, which would otherwise fall apart (especially in large vessels)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the steps for the formation of the fibrin clot?

A
  1. Activate coagulation factor
  2. Set off coagulation cascade
  3. Production of fibrin from fibrinogen
  4. Formation of fibrin mesh
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the methods by which coagulation factors are activated?

A
  1. Intrinsic pathway (all components in the plasma) - subendothelial collagen (protein) lies under endothelial cells unexposed to the blood, so when the cell is damaged, this protein is released into the blood, activating coagulation factors that trigger the coagulation cascade
  2. Extrinsic pathway - Tissue Factor (TF) is secreted by endothelial cells when they are damaged, activating coagulation factors that trigger the coagulation cascade
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the coagulation cascade?

A

Following the activation of one coagulation factor, consequent coagulation factors are activated, eventually leading to the production of fibrin. It goes through the initiation, amplification and propagation phases, leading to a rapid burst of thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which vitamin is important for the coagulation factors?

A

Vitamin K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the difference between fibrin and fibrinogen and how is fibrin producted?

A

Fibrinogen is fibrin with a protein attached to it, so after the coagulation cascade, the enzyme thrombin cleaves the fibrinogen to form fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Which 2 things are essential for the formation of the fibrin mesh?

A

It requires Ca2+ (released during primary haemostasis), and the phospholipid surface of the platelet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Why is Ca2+ important?

A

Has an important role in the binding of activated clotting factors to the phospholipid surfaces of platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Why is the phospholipid surface important?

A

Links the formation of the fibrin mesh with the initial plug - forming the stable clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Why are there coagulation inhibitory mechanisms?

A

Prevent blood from clotting completely and blocking the blood vessel
Ensures coagulation is confined to the site of injury and prevent the spontaneous activation of coagulation

28
Q

What are the 2 coagulation inhibitory systems?

A

Anti-coagulation and thrombolysis

29
Q

What is anti-coagulation?

A

Prevention of blood clots forming

30
Q

Which parts of the coagulation process can anti-coagulation work on?

A

It can either prevent primary haemostasis or secondary haemostasis

31
Q

How can primary haemostasis be prevented?

A

Healthy endothelial cells release molecules that prevent coagulation, such as prostacyclin and nitric oxide, which prevent platelets from binding to the endothelial cells, and cause vasodilation of the blood vessel

32
Q

How can secondary haemostasis be prevented?

A
  1. A heparin like molecule interacts with the inhibitor, antithrombin, and together they inhibit the enzyme thrombin (and factor X). This reduces the production of fibrin from fibrinogen, so a fibrin mesh cannot be formed
  2. Thrombin binds to thrombodulin on the endothelial cell, activating protein C, which in the presence of protein S inactivates other coagulation factors
33
Q

What is artificial anti-coagulation?

A

Anti-coagulant drugs e.g. heparin, warfarin, and DOACs (direct oral anticoagulants)

34
Q

What are anti-coagulant drugs used to treat?

A

Thrombosis

35
Q

How is heparin taken and how does it work?

A

Intravenously, it upregulates the action of antithrombin

36
Q

How is warfarin taken and how does it work?

A

Orally, as a tablet. It is a vitamin K antagonist, hence prevents the synthesis of coagulation factors (rather than inhibiting existing factor molecules), it takes several days to take effect

37
Q

How are DOACs taken and how do they work?

A

Direct oral anticoagulants (DOACs) are orally available drugs that directly inhibit either thrombin or factor Xa (i.e. without the involvement of antithrombin)

38
Q

What does the fibrinolytic system do?

A

Carries out fibrinolysis, the break down of the clot

39
Q

What is the principle enzyme in the fibrinolytic system and how does it circulate around the body?

A

Plasmin

Circulates in its inactive form, plasminogen

40
Q

What activates plasminogen?

A

Tissue plasminogen activator (t-PA) activates plasminogen only when brought together by binding on lysine residues on fibrin

41
Q

What does the breakdown of fibrin produce?

A

Leads to the generation of fibrin-degradation produces (FDPs)

42
Q

What else can fibrin break down and how is this controlled?

A

Other proteins in the plasma e.g. fibrinogen and some coagulation factors.
Antiplasmin circulates the blood and inhibits plasmin

43
Q

What is thrombolytic therapy?

A

Administering thrombolytic agents to break up the clot. Used to treat life threatening pulmonary emboli and/or ischaemic strokes

44
Q

How do the thrombolytic agents work?

A

Agents such as t-PA work by generating plasmin to lyse clots and are administered intravenously to selected patients

45
Q

When do these thrombolytic agents need to be given to be effective?

A

As quickly as possible, preferably within one hour of the onset of symptoms

46
Q

Risks of thrombolytic therapy?

A

Bleeding

47
Q

What is a common antifibrinolytic drug?

A

Tranexamic acid

48
Q

How does Tranexamic acid work?

A

Competitive inhibitor
Synthetic derivative of lysine, and binds to plasminogen
This means the lysine residues on the fibrin are unable to bind to the plasminogen to activate it to plasmin
Reduced plasmin generation results in suppression of fibrinolysis

49
Q

Where are antifibrinolytic drugs used?

A

To treat bleeding in trauma and surgical patients as well as in patients with inherited bleeding disorders

50
Q

What are the 2 methods to test coagulation time?

A
  1. Prothrombin time (PT)

2. Activated partial thromboplastin time (APTT)

51
Q

What is the process of measuring Prothrombin time (PT)?

A

Blood collected in a bottle containing sodium citrate, which forms chelates with Ca2+ to prevent blood clotting in the bottle
The sample is spun to produce platelet-poor plasma
TF, phospholipids (or nowadays, recombinant thromboplastin is often used as the source of both TF and phospholipid) and Ca2+ are added to the citrated plasma sample, the length of time taken for the mixture to clot is recorded

52
Q

Why might the Prothrombin time (PT) be prolonged?

A

Reduction in the activity in the coagulation factors (specifically Factor II, Factor V, Factor XII or Factor X) or fibrinogen

53
Q

When PT is used to monitor anticoagulant agents (E.g. warfarin), the units are?

A

International normalised ratio (INR)

54
Q

What is the process to measure activated partial thromboplastin time (APTT)

A

Contact activator (e.g. glass or silica) to activate factor XII, phospholipid and calcium is added to the citrated plasma sample. The time taken for this mixture to clot is measured

55
Q

Why might the activated partial thromboplastin time (APTT) be prolonged?

A

Reduction in a single or multiple clotting factors -Factor VIII or IX

56
Q

Which factor deficiency does not cause bleeding?

A

Factor XII

57
Q

What are 3 possible causes of bleeding?

A
  1. Reduction in platelet number or function (primary haemostasis –platelet plug)
  2. Reduction in coagulation factor(s) (secondary haemostasis – fibrin clot)
  3. Increased fibrinolysis
58
Q

Why might there be a reduction in platelet number?

A
  1. Failure of platelet production: drugs, viruses, bone marrow infiltration, megaloblastic anaemia resulting from B12 or folate deficiency, hereditary thrombocytopenia
  2. Shortened platelet survival – immune thrombocytopenia, disseminated intravascular coagulation (DIC)
  3. Increased splenic pooling
59
Q

Why might there be a reduction in platelet function?

A
  1. Antiplatelet drugs e.g. aspirin

2. Inherited causes

60
Q

What are the 2 broad reasons to why blood abnormalities may arise?

A
  1. Congenital

2. Acquired

61
Q

Why might there be a reduction in coagulation factors?

A

Congenital causes:
1. von Willebrand disease (VWD) - autosomal - reductions in the level or function of von Willebrand factor (VWF)
2. Haemophilia A - factor VIII deficiency, X linked – males affected, females carriers
3. Haemophilia B - factor IX deficiency, X linked – males affected, females carriers
Acquired:
1. Liver disease
2. Aniticoagulant drugs
3. Disseminated intravascular coagulation (DIC) - TF activated = uncontrolled activation of coagulation = activation of the fibrinolytic system = large amounts of thrombin released = huge consumption of platelets = fibrinolysis activation = high levels of fibrin degradation products (FDPs)

62
Q

What may trigger DIC?

A

Many reasons including bacterial sepsis, advanced cancer and a variety of obstetric emergencies

63
Q

How can DIC be treated?

A

Replacement of missing clotting factors and platelets may help control the bleeding symptoms (but root cause also needs to be dealt with for long term management)

64
Q

Why might there be increased fibrinolysis (causing bleeding)?

A
  1. DIC

2. Thrombolytic therapy - anticoagulant drugs

65
Q

What are the 3 contributory factors to thrombosis in ‘Virchow’s triad’?

A
  1. Blood: dominant in venous thrombosis
  2. Vessel wall: dominant in arterial thrombosis
  3. Blood flow: complex, contributes to both arterial and venous thrombosis
66
Q

What changes in the blood can increase the chances of a venous thrombosis?

A
  1. Reduced levels of anticoagulant proteins (usually genetic basis e.g. thrombophilia)
  2. Reduced fibrinolytic activity (e.g during pregnancy plasminogen is inhibited)
  3. Increased levels of clotting factors or platelets

Y1 - PoM - Week 1 (21 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions